nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—SULT1E1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.112	0.133	CbGpPWpGaD
Cyclizine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.111	0.132	CbGpPWpGaD
Cyclizine—SULT1E1—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.0315	0.0375	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0302	0.036	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0296	0.0352	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0254	0.0302	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0249	0.0296	CbGpPWpGaD
Cyclizine—SULT1E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0184	0.0219	CbGpPWpGaD
Cyclizine—SULT1E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.0183	0.0218	CbGpPWpGaD
Cyclizine—SULT1E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0182	0.0216	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0179	0.0213	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0173	0.0205	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0167	0.0198	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0162	0.0192	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0159	0.0189	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0157	0.0187	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0151	0.0179	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0146	0.0174	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.014	0.0167	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0136	0.0162	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0134	0.0159	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0132	0.0157	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0123	0.0146	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0102	0.0122	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0086	0.0102	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00754	0.00897	CbGpPWpGaD
Cyclizine—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.00732	0.046	CrCbGaD
Cyclizine—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.00722	0.0453	CrCbGaD
Cyclizine—Bepridil—CACNA1C—attention deficit hyperactivity disorder	0.00681	0.0428	CrCbGaD
Cyclizine—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.00668	0.0419	CrCbGaD
Cyclizine—Cinnarizine—CACNA1C—attention deficit hyperactivity disorder	0.00619	0.0389	CrCbGaD
Cyclizine—Loxapine—DRD5—attention deficit hyperactivity disorder	0.00617	0.0387	CrCbGaD
Cyclizine—Reboxetine—SLC6A4—attention deficit hyperactivity disorder	0.00605	0.038	CrCbGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00583	0.00694	CbGpPWpGaD
Cyclizine—Loxapine—ADRA2C—attention deficit hyperactivity disorder	0.00582	0.0365	CrCbGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00572	0.0068	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00568	0.00675	CbGpPWpGaD
Cyclizine—Clozapine—HRH3—attention deficit hyperactivity disorder	0.00535	0.0336	CrCbGaD
Cyclizine—SULT1E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.0052	0.00619	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.0052	0.00619	CbGpPWpGaD
Cyclizine—Benzatropine—SLC6A3—attention deficit hyperactivity disorder	0.00512	0.0322	CrCbGaD
Cyclizine—SULT1E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00512	0.00609	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.005	0.00595	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0049	0.00582	CbGpPWpGaD
Cyclizine—Clozapine—ADRA2C—attention deficit hyperactivity disorder	0.00488	0.0307	CrCbGaD
Cyclizine—SULT1E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00476	0.00566	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00416	0.00495	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00396	0.00471	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00396	0.00471	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00381	0.00453	CbGpPWpGaD
Cyclizine—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.00379	0.0238	CrCbGaD
Cyclizine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.00379	0.0238	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00373	0.00444	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00372	0.00442	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00366	0.00435	CbGpPWpGaD
Cyclizine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.00361	0.0227	CrCbGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00346	0.00412	CbGpPWpGaD
Cyclizine—Mianserin—DRD3—attention deficit hyperactivity disorder	0.00342	0.0215	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00339	0.00404	CbGpPWpGaD
Cyclizine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00329	0.0206	CrCbGaD
Cyclizine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.00326	0.0205	CrCbGaD
Cyclizine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00322	0.0202	CrCbGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00322	0.00383	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00321	0.00381	CbGpPWpGaD
Cyclizine—Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.00319	0.02	CrCbGaD
Cyclizine—Loxapine—DRD4—attention deficit hyperactivity disorder	0.00316	0.0198	CrCbGaD
Cyclizine—SULT1E1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00315	0.00375	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00313	0.00372	CbGpPWpGaD
Cyclizine—Cyproheptadine—DRD2—attention deficit hyperactivity disorder	0.00313	0.0196	CrCbGaD
Cyclizine—Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.00312	0.0196	CrCbGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00312	0.00371	CbGpPWpGaD
Cyclizine—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00308	0.0193	CrCbGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00307	0.00365	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00303	0.0036	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00297	0.00353	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00291	0.00346	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00282	0.00335	CbGpPWpGaD
Cyclizine—Loxapine—HTR1B—attention deficit hyperactivity disorder	0.0028	0.0176	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00276	0.00328	CbGpPWpGaD
Cyclizine—Cinnarizine—DRD2—attention deficit hyperactivity disorder	0.00273	0.0171	CrCbGaD
Cyclizine—Loxapine—DRD3—attention deficit hyperactivity disorder	0.00272	0.0171	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00267	0.00318	CbGpPWpGaD
Cyclizine—Loxapine—DRD1—attention deficit hyperactivity disorder	0.00267	0.0168	CrCbGaD
Cyclizine—Clozapine—DRD4—attention deficit hyperactivity disorder	0.00265	0.0166	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00263	0.00312	CbGpPWpGaD
Cyclizine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.00262	0.0165	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00259	0.00308	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00259	0.00307	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00256	0.00304	CbGpPWpGaD
Cyclizine—Loxapine—SLC6A3—attention deficit hyperactivity disorder	0.00253	0.0159	CrCbGaD
Cyclizine—Loxapine—ADRA2A—attention deficit hyperactivity disorder	0.00248	0.0156	CrCbGaD
Cyclizine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.00244	0.0153	CrCbGaD
Cyclizine—Cyproheptadine—HTR2A—attention deficit hyperactivity disorder	0.00242	0.0152	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00242	0.00287	CbGpPWpGaD
Cyclizine—Mianserin—SLC6A4—attention deficit hyperactivity disorder	0.00238	0.015	CrCbGaD
Cyclizine—Mianserin—DRD2—attention deficit hyperactivity disorder	0.00237	0.0149	CrCbGaD
Cyclizine—Clozapine—HTR1B—attention deficit hyperactivity disorder	0.00235	0.0148	CrCbGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00229	0.00272	CbGpPWpGaD
Cyclizine—Clozapine—DRD3—attention deficit hyperactivity disorder	0.00228	0.0144	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00226	0.00269	CbGpPWpGaD
Cyclizine—Clozapine—DRD1—attention deficit hyperactivity disorder	0.00224	0.0141	CrCbGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00215	0.00256	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00211	0.00251	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0021	0.0025	CbGpPWpGaD
Cyclizine—Clozapine—ADRA2A—attention deficit hyperactivity disorder	0.00208	0.0131	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00203	0.00242	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.002	0.00238	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00199	0.00236	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00198	0.00235	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00198	0.00235	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00197	0.00235	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00196	0.00233	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00195	0.00232	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00191	0.00228	CbGpPWpGaD
Cyclizine—Loxapine—SLC6A4—attention deficit hyperactivity disorder	0.00189	0.0119	CrCbGaD
Cyclizine—Loxapine—DRD2—attention deficit hyperactivity disorder	0.00188	0.0118	CrCbGaD
Cyclizine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.00187	0.0118	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00184	0.00219	CbGpPWpGaD
Cyclizine—Mianserin—HTR2A—attention deficit hyperactivity disorder	0.00183	0.0115	CrCbGaD
Cyclizine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00172	0.00205	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00169	0.00201	CbGpPWpGaD
Cyclizine—Clozapine—DRD2—attention deficit hyperactivity disorder	0.00158	0.00993	CrCbGaD
Cyclizine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00146	0.00174	CbGpPWpGaD
Cyclizine—Loxapine—HTR2A—attention deficit hyperactivity disorder	0.00145	0.00914	CrCbGaD
Cyclizine—SULT1E1—Metabolism—EP300—attention deficit hyperactivity disorder	0.00135	0.00161	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00134	0.0016	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00133	0.00158	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00129	0.00153	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00128	0.00152	CbGpPWpGaD
Cyclizine—Clozapine—HTR2A—attention deficit hyperactivity disorder	0.00122	0.00767	CrCbGaD
Cyclizine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00119	0.00141	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00116	0.00138	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00115	0.00137	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00115	0.00137	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00113	0.00134	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00113	0.00134	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00112	0.00133	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00111	0.00132	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00108	0.00128	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00104	0.00124	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00104	0.00124	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.00122	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00101	0.00121	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000944	0.00112	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000813	0.000967	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000784	0.000932	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000728	0.000866	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000685	0.000815	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000661	0.000786	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000637	0.000757	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000617	0.000734	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000606	0.000721	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000599	0.000712	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000561	0.000667	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000561	0.000667	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000558	0.000663	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000552	0.000657	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000513	0.00061	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000449	0.000533	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000427	0.000508	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000391	0.000465	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.00034	0.000404	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000338	0.000401	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000327	0.000389	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000207	0.000246	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	0.000146	0.000173	CbGpPWpGaD
